The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel

Vaccine

Volumn 30, Issue 35, 2012, Pages 5240-5245

  Greiner, Vanille J ^a   Ronzon, Frédéric ^b   Larquet, Eric ^c   Desbat, Bernard ^d   Estèves, Catherine ^b   Bonvin, Julie ^b   Gréco, Frédéric ^b   Manin, Catherine ^b   Klymchenko, Andrey S ^a   Mély, Yves ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b SANOFI PASTEUR   (France)

^c LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Aluminium hydroxide adjuvant; Fluorescence spectroscopy; Hepatitis B surface antigen

Indexed keywords

3 HYDROXYFLAVONE; ALUMINUM HYDROXIDE; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY; RF 1 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VITRONECTIN;

ANTIGEN STRUCTURE; ARTICLE; ELECTRON MICROSCOPY; FLUORESCENCE ANALYSIS; GEL; INFRARED SPECTROSCOPY; LIPID ABSORPTION; LIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAMAN SPECTROMETRY; SURFACE PLASMON RESONANCE;

ADSORPTION; ALUMINUM HYDROXIDE; CIRCULAR DICHROISM; FLAVONOIDS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; LIPIDS; MICROSCOPY, ELECTRON; PROTEIN STRUCTURE, SECONDARY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, INFRARED; SURFACE PLASMON RESONANCE; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84863834719     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.05.082     Document Type: Article

References (43)

1. Ganem D., Varmus H.E. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987, 56:651-693.
2. Robinson W.S., Lutwick L.I. The virus of hepatitis, type B (first of two parts). N Engl J Med 1976, 295(November (21)):1168-1175.
3. McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R. Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307(January (5947)):178-180.
4. Diminsky D., Schirmbeck R., Reimann J., Barenholz Y. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 1997, 15(April-May (6-7)):637-647.
5. Diminsky D., Moav N., Gorecki M., Barenholz Y. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 1999, 18(August (1-2)):3-17.
6. Gilbert R.J., Beales L., Blond D., Simon M.N., Lin B.Y., Chisari F.V., et al. Hepatitis B small surface antigen particles are octahedral. Proc Natl Acad Sci U S A 2005, 102(October (41)):14783-14788.
7. Satoh O., Imai H., Yoneyama T., Miyamura T., Utsumi H., Inoue K., et al. Membrane structure of the hepatitis B virus surface antigen particle. J Biochem 2000, 127(April (4)):543-550.
8. Guerrero E., Gavilanes F., Peterson D.L. Model for the protein arrangement in HBsAg particles based on physical and chemical studies. Viral hepatitis and liver disease 1988, 606-613. Alan R Liss Inc., New York.
9. Gavilanes F., Gonzalez-Ros J.M., Peterson D.L. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem 1982, 257(July (13)):7770-7777.
10. Satoh O., Umeda M., Imai H., Tunoo H., Inoue K. Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines. J Lipid Res 1990, 31(July (7)):1293-1300.
11. Gavilanes F., Gomez-Gutierrez J., Aracil M., Gonzalez-Ros J.M., Ferragut J.A., Guerrero E., et al. Hepatitis B surface antigen. Role of lipids in maintaining the structural and antigenic properties of protein components. Biochem J 1990, 265(February (3)):857-864.
12. Aggerbeck L.P., Peterson D.L. Electron microscopic and solution X-ray scattering observations on the structure of hepatitis B surface antigen. Virology 1985, 141(February (1)):155-161.
13. Stirk H.J., Thornton J.M., Howard C.R. A topological model for hepatitis B surface antigen. Intervirology 1992, 33(3):148-158.
14. Zhao Q., Wang Y., Freed D., Fu T.M., Gimenez J.A., Sitrin R.D., et al. Maturation of recombinant hepatitis B virus surface antigen particles. Hum Vaccin 2006, 2(July-August (4)):174-180.
15. Greiner V.J., Egele C., Oncul S., Ronzon F., Manin C., Klymchenko A., et al. Characterization of the lipid and protein organization in HBsAg viral particles by steady-state and time-resolved fluorescence spectroscopy. Biochimie 2010, 92(August (8)):994-1002.
16. Milhiet P.E., Dosset P., Godefroy C., Le Grimellec C., Guigner J.M., Larquet E., et al. Nanoscale topography of hepatitis B antigen particles by atomic force microscopy. Biochimie 2010, 93(February (2)):254-259.
17. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998, 32(July (3)):155-172.
18. Morefield G.L., Sokolovska A., Jiang D., HogenEsch H., Robinson J.P., Hem S.L. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 2005, 23(February (13)):1588-1595.
19. Li H., Nookala S., Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol 2007, 178(April (8)):5271-5276.
20. Sokolovska A., Hem S.L., HogenEsch H. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine 2007, 25(June (23)):4575-4585.
21. Iyer S., Robinett R.S., HogenEsch H., Hem S.L. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine 2004, 22(March (11-12)):1475-1479.
22. Baier R.E., Dutton R.C. Initial events in interactions of blood with a foreign surface. J Biomed Mater Res 1969, 3(March (1)):191-206.
23. Heimlich J.M., Regnier F.E., White J.L., Hem S.L. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins. Vaccine 1999, 17(July (22)):2873-2881.
24. Hem S.L., HogenEsch H., Middaugh C.R., Volkin D.B. Preformulation studies - the next advance in aluminum adjuvant-containing vaccines. Vaccine 2010, 28(July (31)):4868-4870.
25. Capelle M.A., Brugger P., Arvinte T. Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity. Vaccine 2005, 23(February (14)):1686-1694.
26. Jones L.S., Peek L.J., Power J., Markham A., Yazzie B., Middaugh C.R. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem 2005, 280(April (14)):13406-13414.
27. Tleugabulova D., Falcon V., Penton E. Evidence for the denaturation of recombinant hepatitis B surface antigen on aluminium hydroxide gel. J Chromatogr B Biomed Sci Appl 1998, 720(December (1-2)):153-163.
28. Hutcheon C.J., Becker J.O., Russell B.A., Bariola P.A., Peterson G.J., Stroop S.D. Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant. Vaccine 2006, 24(November (49-50)):7214-7225.
29. Rinella J.V., Workman R.F., Hermodson M.A., White J.L., Hem S.L. Elutability of proteins from aluminum-containing vaccine adjuvants by treatment with surfactants. J Colloid Interface Sci 1998, 197(January (1)):48-56.
30. Rinella J.V., White J.L., Hem S.L. Effect of pH on the elution of model antigens from aluminum-containing adjuvants. J Colloid Interface Sci 1998, 205(September (1)):161-165.
31. Egan P.M., Belfast M.T., Gimenez J.A., Sitrin R.D., Mancinelli R.J. Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine. Vaccine 2009, 27(May (24)):3175-3180.
32. Klymchenko A.S., Duportail G., Ozturk T., Pivovarenko V.G., Mely Y., Demchenko A.P. Novel two-band ratiometric fluorescence probes with different location and orientation in phospholipid membranes. Chem Biol 2002, 9(November (11)):1199-1208.
33. Ozturk T., Klymchenko A.S., Capan A., Oncul S., Cikrikci S., Taskiran S., et al. New 3-hydroxyflavone derivatives for probing hydrophobic sites in microheterogeneous systems. Tetrahedron 2007, 63(41):10290-10299.
34. Shynkar V.V., Klymchenko A.S., Duportail G., Demchenko A.P., Mely Y. Two-color fluorescent probes for imaging the dipole potential of cell plasma membranes. Biochim Biophys Acta 2005, 1712(June (2)):128-136.
35. Iwarson S., Tabor E., Thomas H.C., Goodall A., Waters J., Snoy P., et al. Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. J Med Virol 1985, 16(May (1)):89-96.
36. Bombarda E., Ababou A., Vuilleumier C., Gerard D., Roques B.P., Piemont E., et al. Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids. Biophys J 1999, 76(March (3)):1561-1570.
37. Ramos P., Coste T., Piemont E., Lessinger J.M., Bousquet J.A., Chapus C., et al. Time-resolved fluorescence allows selective monitoring of Trp30 environmental changes in the seven-Trp-containing human pancreatic lipase. Biochemistry 2003, 42(November (43)):12488-12496.
38. Shi L., Caulfield M.J., Chern R.T., Wilson R.A., Sanyal G., Volkin D.B. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 2002, 91(April (4)):1019-1035.
39. Ray K., Szmacinski H., Lakowicz J.R. Enhanced fluorescence of proteins and label-free bioassays using aluminum nanostructures. Anal Chem 2009, 81(August (15)):6049-6054.
40. Demchenko A.P., Mely Y., Duportail G., Klymchenko A.S. Monitoring biophysical properties of lipid membranes by environment-sensitive fluorescent probes. Biophys J 2009, 96(May (9)):3461-3470.
41. Klymchenko A.S., Mely Y., Demchenko A.P., Duportail G. Simultaneous probing of hydration and polarity of lipid bilayers with 3-hydroxyflavone fluorescent dyes. Biochim Biophys Acta 2004, 1665(October (1-2)):6-19.
42. Dong A., Jones L.S., Kerwin B.A., Krishnan S., Carpenter J.F. Secondary structures of proteins adsorbed onto aluminum hydroxide: infrared spectroscopic analysis of proteins from low solution concentrations. Anal Biochem 2006, 351(April (2)):282-289.
43. Hansen B., Belfast M., Soung G., Song L., Egan P.M., Capen R., et al. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine 2009, 27(February (6)):888-892.